Perinatal death:
Ten studies examined the association of pravastatin with perinatal
death. Although statistical significance was not reached, there was a
trend toward a decrease in the risk for perinatal death in newborns of
women treated with pravastatin (OR=0.32, 95%CI:0.09-1.13, p=0.08,
I2=54%) (Figure 4).